Lars Erik Bryld

Lars Erik Bryld serves as a Clinical Associate Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. His primary clinical focus is within Dermatovenerology, with practice locations in Roskilde (Køgevej 7-13) and Copenhagen (Blegdamsvej 3). He is actively involved in clinical research related to biologic therapies for dermatological conditions, particularly psoriasis.

Dr. Bryld's research interests center on dermatological therapeutics, with specific expertise in biologic agents and biosimilars for psoriasis treatment. His work extensively examines drug survival rates, treatment efficacy, and real-world outcomes of biologic therapies across various dermatological conditions. His research program leverages large-scale registry data from Danish national healthcare registries to generate evidence on optimal treatment strategies for chronic inflammatory skin diseases.

His publication record demonstrates significant contributions to understanding treatment patterns and outcomes for psoriasis, with particular emphasis on non-medical switching from originator biologics to biosimilars, drug retention rates, and treatment response predictors. His research has been cited extensively and has influenced clinical practice guidelines in dermatology.

Dr. Bryld collaborates extensively with leading dermatology researchers across Denmark, particularly within the DERMBIO registry network, contributing to numerous high-impact publications in top dermatology and rheumatology journals including JAMA Dermatology, Journal of Investigative Dermatology, and Acta Dermato-Venereologica.